Abstract

Clonal heterogeneity and evolution has major implications for disease progression and relapse in acute myeloid leukemia (AML). To model clonal dynamics in vivo, we serially transplanted 23 AML cases to immunodeficient mice and followed clonal composition for up to 15 months by whole-exome sequencing of 84 xenografts across two generations. We demonstrate vast changes in clonality that both progress and reverse over time, and define five patterns of clonal dynamics: Monoclonal, Stable, Loss, Expansion and Burst. We also show that subclonal expansion in vivo correlates with a more adverse prognosis. Furthermore, clonal expansion enabled detection of very rare clones with AML driver mutations that were undetectable by sequencing at diagnosis, demonstrating that the vast majority of AML cases harbor multiple clones already at diagnosis. Finally, the rise and fall of related clones enabled deconstruction of the complex evolutionary hierarchies of the clones that compete to shape AML over time.

Clonal evolution and heterogeneity has strong implications for treatment response in acute myeloid leukemia. Here, the authors use patient derived in vivo modelling to highlight the complex clonal and evolutionary dynamics underpinning acute myeloid leukemia progression.

Details

Title
Clonal competition within complex evolutionary hierarchies shapes AML over time
Author
Sandén, Carl 1   VIAFID ORCID Logo  ; Lilljebjörn Henrik 1   VIAFID ORCID Logo  ; Orsmark Pietras Christina 1 ; Henningsson Rasmus 1 ; Saba, Karim H 1   VIAFID ORCID Logo  ; Landberg Niklas 2   VIAFID ORCID Logo  ; Thorsson Hanna 1 ; von Palffy Sofia 1   VIAFID ORCID Logo  ; Peña-Martinez, Pablo 1   VIAFID ORCID Logo  ; Högberg, Carl 1 ; Rissler, Marianne 1 ; Gisselsson, David 1   VIAFID ORCID Logo  ; Lazarevic, Vladimir 3   VIAFID ORCID Logo  ; Juliusson Gunnar 3 ; Ågerstam Helena 1 ; Fioretos Thoas 1 

 Lund University, Division of Clinical Genetics, Department of Laboratory Medicine, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361) 
 Lund University, Division of Clinical Genetics, Department of Laboratory Medicine, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361); Skåne University Hospital, Department of Hematology, Oncology and Radiation Physics, Lund, Sweden (GRID:grid.411843.b) (ISNI:0000 0004 0623 9987) 
 Skåne University Hospital, Department of Hematology, Oncology and Radiation Physics, Lund, Sweden (GRID:grid.411843.b) (ISNI:0000 0004 0623 9987) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2351473267
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.